Navigating an executive leadership change? Use our eBook to facilitate a smooth transition.Download Now

Westicke Partners

Close

Westwicke Blog

The Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

10 Disclosure Guidelines for Clinical Trial Data and Milestones

Posted on October 21st, 2020. Posted by

As life science and medical device companies seek regulatory approval for their products, they will likely encounter difficult disclosure decisions around clinical and regulatory events. Clinical trial data and milestones can present great opportunities as well as significant challenges.

Continue Reading

How to Make the Most of Virtual Non-Deal Roadshows

Posted on October 8th, 2020. Posted by

Virtual Non-Deal Roadshows

The challenges of functioning successfully in an extended COVID-19 environment have presented many new ways of doing business. This is especially evident for events such as non-deal roadshows (NDRs).

Continue Reading

6 Commonly Asked Questions (and Answers) About Quiet Periods

Posted on September 9th, 2020. Posted by

Commonly Asked Questions About Quiet Periods

Public healthcare companies often question the best course of action during quiet periods — those stretches of time during which they should limit their interaction with Wall Street due to their knowledge of material and timely information that has not yet been disclosed. Specifically, management teams struggle to figure out what the quiet period means for their investor relations (IR) efforts.

Continue Reading

Form 8-K vs. Press Release: What’s the Difference?

Posted on August 19th, 2020. Posted by

Form 8-K vs. Press Release

There are many things public companies must consider when disseminating news. What is the most appropriate vehicle to disclose news to investors? In some instances, you will need to file a Form 8-K, the disclosure from the Security and Exchange Commission (SEC). Sometimes, the news will necessitate issuing a press release. And sometimes, you will file both.

Continue Reading

12 Elements Your Investor Relations Website Must Include

Posted on July 8th, 2020. Posted by

Westwicke Investor Relations Website Checklist

Today, potential investors who are interested in learning about your company will likely visit your website before anything else. To make a good first impression, your investor relations website should be informative, appealing, and easy to navigate. This will allow investors to quickly understand all the fundamentals of your business before setting up a time to meet with management.

Continue Reading

COVID-19 Guidance for Businesses: How to Handle Scheduled Events Like Investor Days

Posted on March 24th, 2020. Posted by

COVID-19 Guidance for Businesses: How to Stay Visible

Over the past few weeks, cities, states, and businesses have begun taking measures to help slow the spread of COVID-19. For many companies, that means encouraging or requiring employees to work from home. For others, it means cancelling conferences, meetings, and investor days.

Continue Reading

4 Critical Elements of an Effective IR Website

Posted on February 20th, 2020. Posted by

IR website

Any company looking to attract market attention today shouldn’t underestimate the importance of a sophisticated corporate website with a high quality investor relations section.

Potential investors interested in learning more about your firm will likely visit your website before anything else, so put your best foot forward by making your IR website appealing and its pages informative and easy to navigate.

Continue Reading

How to Conduct a Perception Audit

Posted on December 18th, 2019. Posted by

Perception Audit

Finding out how others view your company can be intimidating, but to make sure your business is headed in the right direction, it’s necessary. A perception audit — an independent investigation into investor and analyst impressions of a company — can help you benchmark your progress over time, identify ways to improve your investor relations plan, and pinpoint any misperceptions in market views. Learn the basics of how to conduct a successful perception audit with this checklist.

Continue Reading

Control the Narrative: 4 Ways to Integrate Investor Relations and Public Relations

Posted on December 12th, 2019. Posted by

IR and PR Integration

In today’s world of ubiquitous, instantaneous, and interconnected information, integrated communication should be a key strategic priority for all companies. However, it is even more important in the healthcare space, especially for early stage, pre-revenue life sciences companies, where the investor story is indistinguishable from the product or technology story.

Many companies struggle to unify their message and deliver a cohesive story to the marketplace. As a consequence, the many other voices in the arena — competitors, analysts, key opinion leaders, regulators, investors, advocacy groups, the media, and others — shape the perception of your company for you.

Continue Reading

Keys to Successful Disclosure of Clinical Trial Data and Milestones

Posted on November 21st, 2019. Posted by

Clinical Disclosure

For publicly traded healthcare companies, clinical trial data and milestone disclosure can present great opportunities as well as significant challenges.

On the path toward regulatory approval, life science and medical device company management will encounter difficult disclosure decisions surrounding clinical and regulatory events. Finding the right balance between the “duty to disclose” vs. “pressure to disclose” dilemma is not easy. If done right, such milestones are a great way to raise visibility within the investment, clinical and scientific communities. If done wrong, the consequences may be severe.

Continue Reading

1 2 3 18

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, Form 8K vs. Press Release: What’s the Difference?

Our Locations